HomeCLSD • NASDAQ
add
Clearside Biomedical Inc
Previous close
$0.86
Day range
$0.85 - $0.91
Year range
$0.70 - $1.65
Market cap
68.28M USD
Avg Volume
148.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.33M | 913.04% |
Operating expense | 7.29M | -13.65% |
Net income | -8.22M | 30.09% |
Net profit margin | -352.92 | 93.10% |
Earnings per share | -0.11 | 35.29% |
EBITDA | -5.15M | 37.07% |
Effective tax rate | -9.52% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.63M | -61.45% |
Total assets | 19.67M | -51.00% |
Total liabilities | 65.58M | 5.85% |
Total equity | -45.91M | — |
Shares outstanding | 76.92M | — |
Price to book | -1.44 | — |
Return on assets | -58.10% | — |
Return on capital | -123.08% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.22M | 30.09% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2011
Headquarters
Website
Employees
32
